IL SB1774 | 2023-2024 | 103rd General Assembly
Status
Completed Legislative Action
Spectrum: Partisan Bill (Democrat 11-0)
Status: Passed on June 30 2023 - 100% progression
Action: 2023-06-30 - Public Act . . . . . . . . . 103-0227
Text: Latest bill text (Chaptered) [HTML]
Spectrum: Partisan Bill (Democrat 11-0)
Status: Passed on June 30 2023 - 100% progression
Action: 2023-06-30 - Public Act . . . . . . . . . 103-0227
Text: Latest bill text (Chaptered) [HTML]
Summary
Amends the Cancer Clinical Trial Participation Program Act. Changes the short title of the Act to the Clinical Trial Participation Program Act. Throughout the Act, replaces references to "cancer clinical trial" with references to "clinical trial" and makes conforming changes. Provides that "clinical trial" includes a voluntary research study conducted on people and designed to answer specific questions about the safety or effectiveness of a drug, vaccine, therapy, medical device, medical diagnostic, or new way of using an existing treatment to treat or diagnose a condition. Defines "condition". Makes other changes. Effective immediately.
Title
CLINICAL TRIAL PARTICIPATION
Sponsors
Roll Calls
2023-05-11 - House - Third Reading in House (Y: 111 N: 0 NV: 2 Abs: 0) [PASS]
2023-03-29 - Senate - Motion in Senate (Y: 57 N: 0 NV: 2 Abs: 0) [PASS]
2023-03-29 - Senate - Motion in Senate (Y: 57 N: 0 NV: 2 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2023-06-30 | Senate | Public Act . . . . . . . . . 103-0227 |
2023-06-30 | Senate | Effective Date June 30, 2023 |
2023-06-30 | Senate | Governor Approved |
2023-06-09 | Senate | Sent to the Governor |
2023-05-11 | Senate | Passed Both Houses |
2023-05-11 | House | Third Reading - Short Debate - Passed 111-000-000 |
2023-05-10 | House | Placed on Calendar Order of 3rd Reading - Short Debate |
2023-05-10 | House | Second Reading - Short Debate |
2023-05-04 | House | Placed on Calendar 2nd Reading - Short Debate |
2023-05-04 | House | Do Pass / Short Debate Appropriations-Health & Human Services Committee; 023-000-000 |
2023-05-03 | House | Added Alternate Co-Sponsor Rep. Margaret Croke |
2023-05-03 | House | Motion to Suspend Rule 21 - Prevailed 071-040-000 |
2023-05-03 | House | Motion Filed to Suspend Rule 21 Human Services Committee; Rep. Robyn Gabel |
2023-04-27 | House | Added Alternate Chief Co-Sponsor Rep. Edgar González, Jr. |
2023-04-26 | House | Committee/Final Action Deadline Extended-9(b) May 19, 2023 |
2023-04-18 | House | Assigned to Appropriations-Health & Human Services Committee |
2023-03-30 | House | Referred to Rules Committee |
2023-03-30 | House | First Reading |
2023-03-30 | House | Chief House Sponsor Rep. Camille Y. Lilly |
2023-03-30 | House | Arrived in House |
2023-03-29 | Senate | Third Reading - Passed; 057-000-000 |
2023-03-28 | Senate | Added as Co-Sponsor Sen. Sara Feigenholtz |
2023-03-23 | Senate | Placed on Calendar Order of 3rd Reading ** March 24, 2023 |
2023-03-13 | Senate | Added as Co-Sponsor Sen. Mary Edly-Allen |
2023-03-10 | Senate | Placed on Calendar Order of 3rd Reading March 21, 2023 |
2023-03-10 | Senate | Second Reading |
2023-03-08 | Senate | Added as Co-Sponsor Sen. Willie Preston |
2023-03-08 | Senate | Placed on Calendar Order of 2nd Reading March 9, 2023 |
2023-03-08 | Senate | Do Pass Public Health; 007-000-000 |
2023-03-07 | Senate | Added as Co-Sponsor Sen. Cristina Castro |
2023-03-03 | Senate | Added as Co-Sponsor Sen. Paul Faraci |
2023-02-27 | Senate | Added as Co-Sponsor Sen. Linda Holmes |
2023-02-21 | Senate | Assigned to Public Health |
2023-02-15 | Senate | Added as Co-Sponsor Sen. Laura M. Murphy |
2023-02-09 | Senate | Referred to Assignments |
2023-02-09 | Senate | First Reading |
2023-02-09 | Senate | Filed with Secretary by Sen. Adriane Johnson |
Code Citations
Chapter | Article | Section | Citation Type | Statute Text |
---|---|---|---|---|
410 | 416 | 1 | Amended Code | Citation Text |
410 | 416 | 10 | Amended Code | Citation Text |
410 | 416 | 15 | Amended Code | Citation Text |
410 | 416 | 20 | Amended Code | Citation Text |
410 | 416 | 25 | Amended Code | Citation Text |
410 | 416 | 30 | Amended Code | Citation Text |
410 | 416 | 5 | Amended Code | Citation Text |